Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 11, 1998

View Archived Issues

Israeli investigators describe studies with novel vitamin D analogue

Hemosol: six-month 1998 highlights

Guilford: Q2 1998 highlights

IBT-9302 demonstrates therapeutic value in the treatment of traumatic shock

Medtronic releases novel cardiac device with diagnostic and therapeutic capabilities in Europe

OspA vaccine prevents Lyme disease and asymptomatic infection

4030W92 antihyperalgesic effect due to preferential action on slow activation state of Na+ channel

Professional advises against the use of antioxidant vitamins for the prevention of heart disease

Antifungal activity of NS-718 highly effective against C. neoformans infections

Dual-action angiotensin II blockers/smooth cell proliferation inhibitors from Bayer

Genentech discovers novel polypeptides for treating shock

New CNS agents described by French team

Yeda, Yissum collaborate in the discovery of tyrosine kinase inhibitors

Hoechst describes new compounds for rheumatoid arthritis and allergy

FDA committee recommends approval of Arava for the treatment of rheumatoid arthritis

Byk Gulden researchers synthesize PDE IV inhibitors with broad therapeutic potential

Bayer discovers new MMP inhibitors for arthritic diseases

Cognetix expands drug discovery capabilities with Viatech Imaging acquisition

COX-2 inhibitors selective for the human enzyme discovered at Nycomed Innovations

New agents for treating constipation presented at IUPHAR meeting

MABE: a new enkephalin analogue with analgesic potential

New antiplatelet agent, PDE III inhibitor, reported by Taiwanese scientists

Searle withdraws support for development of CCD-3693; CoCensys will forge ahead

Studies with spheron-targeted AD treatment candidate yield promising results

RS-601, a dual-action TxA2/LTD4 antagonist with potent antiasthmatic effects

Dual ETA/ETB antagonist provides effective blood pressure control in rats

OPC-51803, a vasopressin V2 agonist with potent antidiuretic activity in rats and dogs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...